Difference between revisions of "DASH Data Guide"

Jump to navigation Jump to search
1,000 bytes added ,  12:11, 16 November 2021
no edit summary
Line 10: Line 10:


When the initial list of desired datasets was created, the DASH project was in the process of holding its first monthly meetings with project stakeholders. At the monthly meetings the candidate datasets and selection justification was presented to the project stakeholders. Their feedback on this information shaped the final selection of measures. The stakeholders led the project team to include data describing several more important factors risk factors such as stress proxy and food security indicators. Once finalized, the Allegheny County Health Department began to collect data appearing in this guide from many different sources.
When the initial list of desired datasets was created, the DASH project was in the process of holding its first monthly meetings with project stakeholders. At the monthly meetings the candidate datasets and selection justification was presented to the project stakeholders. Their feedback on this information shaped the final selection of measures. The stakeholders led the project team to include data describing several more important factors risk factors such as stress proxy and food security indicators. Once finalized, the Allegheny County Health Department began to collect data appearing in this guide from many different sources.
== Dataset-specific guides ==
=== Anxiety and Depression Medication ===
These datasets described here provide de-identified diagnosis data for customers (medicare, medicaid, individual, and corporate) of three managed care organizations in Allegheny County (Gateway Health Plan, Highmark Health, and UPMC) that have filed a claim for anxiety or depression medications in 2015. The data also includes the number of enrolled members in the three participating managed care organizations in 2015.
The anxiety and depression datasets were requested after the initial data list had been collected because members of the DASH Partnership wanted to explore the relationship between anxiety and depression with cardiovascular disease following receipt of the cardiovascular disease data. There is evidence that depression is a risk factor for cardiovascular disease.<ref>https://www.heartfoundation.org.au/images/uploads/publications/Beyondblue_depression_CHD.pdf</ref>
[[DASH Guide:Anxiety Medication]]


== Partners ==
== Partners ==

Navigation menu